EW
BMY icon

Elyxium Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Elyxium Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
+3,912
New +$225K 0.02% 272
2026
Q1 		– Sell
-1,450
Closed -$78.2K – 294
2025
Q4 		$78.2K Buy
+1,450
New +$69.8K 0.02% 278
2025
Q2 		– Sell
-4,201
Closed -$256K – 165
2025
Q1 		$256K Buy
+4,201
New +$245K 0.11% 135

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Elyxium Wealth's BMY Position: Q2 2026 in Review

Elyxium Wealth opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 3,912 shares worth $225K. The stake represents 0.02% of the portfolio and ranks #272 among its holdings. This is a return to the name: Elyxium Wealth previously reported a position in BMY as recently as Q4 2025.

Elyxium Wealth first reported a position in BMY in Q1 2025 and has held it in 3 quarters since. The position peaked at $256K in Q1 2025. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Elyxium Wealth held 3,912 shares of Bristol-Myers Squibb worth $225K as of Q2 2026.
  • Bristol-Myers Squibb was a new Elyxium Wealth position in Q2 2026.
  • Bristol-Myers Squibb made up 0.02% of Elyxium Wealth's portfolio in Q2 2026, its #272 holding.
  • Elyxium Wealth first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 3 quarters since.
  • Elyxium Wealth's Bristol-Myers Squibb position peaked at $256K in Q1 2025.
  • 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Elyxium Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.